North America Analysis
Home Search

chemotherapy - search results

If you're not happy with the results, please do another search

Nanotherapy and its role in multiple myeloma treatment

A new class of nanotherapy blockades the genetic drive for multiple myeloma progression. Gregory M. Lanza and Michael H Tomasson, of Department of Medicine, Washington University School of Medicine explain... Multiple myeloma is malignancy of plasma cells that reside in the bone marrow and normally function as part of our immune defence...

Development of multiple drug resistance (MDR)

Terra G. Arnason and Troy A.A. Harkness from the Departments of Medicine, and Anatomy and Cell Biology at the University of Saskatchewan detail current strategies to prevent or reverse multiple drug resistant malignancy… Multiple drug resistance (MDR) can be present from the outset (inherent) or develop (acquired) in response to...

Molecular and cellular mechanisms of cancer

Professor Wen Jiang, Dr Andrew Sanders and Dr Lin Ye from the Cardiff China Medical Research Collaborative, Cardiff University School of Medicine highlight the work being done to combat cancer and develop new treatments… Cancer presents a serious issue worldwide for healthcare systems and results in substantial morbidity and mortality for...

Platelets in hemostasis and thrombosis – finding the right balance

Nucleated blood platelets are produced by their bone marrow resident precursors, the megakaryocytes, in a unique process in mammalian physiology. Terminally differentiated, polyploid megakaryocytes are the largest cells in the bone marrow evolving from hematopoietic stem cells. Megakaryocytes are localised in close proximity to sinusoidal blood vessels and convert...
Gynecologic cancer

Research at Oslo University Hospital in the field of Gynaecologic cancer

Oslo University Hospital (OUS) is a big hospital formed by the merger of 4 hospitals. The State Hospital, the Norwegian Radium Hospital, Ullevaal Hospital and Aker Hospital. It serves as a local hospital for about 600,000 inhabitants and as a referral centre for about 2.8 million people. As a...

Improved cancer care: Integrating palliative care and oncology

Norwegian cancer researchers launch a project to improve care for cancer patients with a limited life expectancy Europe has about 3.5 million new cancer cases per year, and the number is rising. Advances in treatment options have led to more patients getting cured and prolonged survival for those with incurable...
NCI

Reducing the burden of cancer

AG highlights the work of the National Cancer Institute (NCI), to reduce and treat cancer. The National Cancer Institute (NCI) is the U.S. Federal government’s primary agency for cancer research and training. As part of the National Institutes of Health (NIH) they coordinate with the National Cancer Programme, which conducts...
Cancer

Prediction of cancer treatment outcome using physics

Vittorio Cristini1,2, Eugene J. Koay3, and Zhihui Wang1,2 1Department of NanoMedicine and Biomedical Engineering, University of Texas Medical School at Houston, Houston, TX 77054, USA 2Brown Foundation Institute of Molecular Medicine, University of Texas Medical School at Houston, Houston, TX 77030, USA 3Department of Radiation Oncology, University of Texas MD Anderson Cancer...
Million dollar question in prostate cancer research

Million dollar question in prostate cancer research

Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer… Most prostate cancers aren’t a problem. In fact, for many the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...

Muscling in on myopenia and myosteatosis

The relationship between body composition and risk of disease has become more clearly understood in recent years, as the technology available to non-invasively quantify components of body mass has improved. Image-based approaches specifically and precisely quantify muscle and fat, while having the capacity to also reveal additional features such...
prostate cancer

The million dollar question in prostate cancer research

Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer Most prostate cancers aren’t a problem. In fact, for many, the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...
Skin cancer: deadly but preventable

Skin cancer: deadly but preventable

Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented… Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...

Cancer imperialism – how to diagnose bone metastases?

Cancer is an unreliable disease. Just as you think you are familiar with it and can begin treating and hopefully curing it, it is no longer as you thought it was. It has coloured its hair, carries other garments, or has changed its lifestyle making it unrecognisable and impossible...

Skin cancer: deadly but preventable

Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...

Follow Open Access Government